Lisa Wilson | In-Site Communications, IR |
Brian Markison | Chief Executive Officer |
James Schaub | Chief Operating Officer |
Michael DePetris | Principal Accounting Officer |
Douglas Tsao | H.C. Wainright |
John Vandermosten | Zacks SCR |
Glen Santangelo | Jefferies |
Good day, and thank you for standing by. Welcome to the RVL Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. [Operator Instructions] Please be advised that today's conference is being recorded.